Hormonal control of disseminated breast cancer
Voznyĭ, E.K.; Meshcheriakova, N.G.; Biakhov, M.I.; Vasiuta, N.I.
Sovetskaia Meditsina 6: 94-97
1990
ISSN/ISBN: 0038-5077 PMID: 2144368 Document Number: 351825
Document emailed within 1 workday
Related Documents
Garin, A.M.; Dmitrieva, N.V.; Vyshinskaia, G.V.; Lichintser, M.R. 1987: Rational combinations of hormonal and cytostatic agents in disseminated forms of breast cancer Voprosy Onkologii 33(11): 13-17Dickson, R.B.; Lippman, M.E. 1986: Hormonal control of human breast cancer cell lines Cancer Surveys 5(3): 617-624
Friedrich, M. 2000: Vitamin D and breast cancer: new approaches for hormonal therapy of breast cancer Clinical and Experimental Obstetrics and Gynecology 27(2): 77-82
Lanfranchi, A. 2014: Normal breast physiology: the reasons hormonal contraceptives and induced abortion increase breast-cancer risk Issues in Law and Medicine 29(1): 135-146
Bethea, T.N.; Rosenberg, L.; Hong, C-Chen.; Troester, M.A.; Lunetta, K.L.; Bandera, E.V.; Schedin, P.; Kolonel, L.N.; Olshan, A.F.; Ambrosone, C.B.; Palmer, J.R. 2015: A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium Breast cancer research: BCR 17: 22
Itoh, S.; Konishi, Y.; Harauchi, D.; Shinoto, M. 1984: Clinical trial of UFT against disseminated breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(11): 2381-2385
Sopkova, V.; Mechl, Z. 1986: Cisplatin (platidiame) in the treatment of patients with disseminated breast cancer Voprosy Onkologii 32(4): 36-38
Ichida, M.; Kataoka, A.; Tsushima, R.; Taguchi, T. 2015: No increase in breast cancer risk in Japanese women taking oral contraceptives: a case-control study investigating reproductive, menstrual and familial risk factors for breast cancer Asian Pacific Journal of Cancer Prevention: Apjcp 16(9): 3685-3690
Marinov, L.; Tsekova, V.; Koĭnov, K.; Velikova, M.; Micheva, D. 1987: Drostanolone propionate (masteril) in disseminated breast cancer in women. Immediate results Khirurgiia 40(6): 80-86
Semiglazova, T.Iu.; Gershanovich, M.L. 2001: Xeloda (capecetabine) in the treatment of disseminated breast cancer after failure with anthracyclines and taxanes Voprosy Onkologii 47(3): 298-302
Murphy, B.; Muss, H.B. 1997: Hormonal therapy of breast cancer: state of the art Oncology 11(5 Suppl 4: 7-13
This, P. 2005: Hormonal replacement therapy and breast cancer La Revue du Praticien 55(4): 377-382
Ecker-Schlipf, B. 1994: Anti-hormonal therapy in breast cancer Medizinische Monatsschrift für Pharmazeuten 17(8): 247-250
Gorins, A. 1984: Cancer of the breast. Influence of hormonal contraception Presse Medicale 13(19): 1207-1210
Jäger, W. 1993: The early detection of disseminated (metastasized) breast cancer by serial tumour marker measurements European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 2(Suppl 3): 133-139
Hortobagyi, G.N.; DiStefano, A.; Legha, S.S.; Buzdar, A.U.; Blumenschein, G.R. 1979: Hormonal therapy with tamoxifen in male breast cancer Cancer Treatment Reports 63(4): 539-541
Rivadeneyra, J. 1977: Progress in the hormonal treatment of advanced cancer of the breast Ginecologia y Obstetricia de Mexico 42(252): 247-249
Rosenberg, K. 2018: Hormonal Contraceptives Increase Breast Cancer Risk American Journal of Nursing 118(3): 69
Lund, E. 1989: The validity of different control groups in a case-control study. Oral contraceptive use and breast cancer in young women Journal of Clinical Epidemiology 42(10): 987-993
Al Saeed, E.F.; Ghabbban, A.J.; Tunio, M.A. 2015: Impact of BMI on Locoregional Control among Saudi Patients with Breast Cancer after Breast Conserving Surgery and Modified Radical Mastectomy Gulf Journal of Oncology 1(17): 7-14